The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia
Madeline Niederkorn(International Society for Experimental Hematology), Daniel T. Starczynowski(Cincinnati Children's Hospital Medical Center)
Cited by 60
Related Papers
Overcoming adaptive therapy resistance in AML by targeting immune response pathways
|Science Translational Medicine|2019|88
Characterization of E1 enzyme dependencies in mutant-UBA1 human cells reveals UBA6 as a novel therapeutic target in VEXAS syndrome
|Leukemia|2025|4
FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndrome
|Journal of Clinical Investigation|2026|0